KYMR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Kymera Therapeutics Inc (KYMR).


$2.61B Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

KYMR Market Cap. (MRY)


KYMR Shares Outstanding (MRY)


KYMR Assets (MRY)


Total Assets

$978.03M

Total Liabilities

$142.42M

Total Investments

$730.65M

KYMR Income (MRY)


Revenue

$47.07M

Net Income

-$223.86M

Operating Expense

$308.71M

KYMR Cash Flow (MRY)


CF Operations

-$194.50M

CF Investing

-$404.08M

CF Financing

$608.85M

KYMR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

KYMR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$978,035,000 (69.87%)

$575,759,000 (-4.54%)

$603,134,000 (-0.46%)

$605,905,000 (24.37%)

Assets Current

$510,268,000 (25.89%)

$405,317,000 (-3.36%)

$419,416,000 (-7.06%)

$451,273,000 (49.26%)

Assets Non-Current

$467,767,000 (174.44%)

$170,442,000 (-7.23%)

$183,718,000 (18.81%)

$154,632,000 (-16.34%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$835,619,000 (111.56%)

$394,971,000 (-19.42%)

$490,151,000 (6.64%)

$459,638,000 (61.91%)

Property Plant & Equipment Net

$97,864,000 (-3.18%)

$101,079,000 (354.43%)

$22,243,000 (4.39%)

$21,307,000 (3.00%)

Cash & Equivalents

$126,050,000 (8.87%)

$115,777,000 (55.35%)

$74,525,000 (37.77%)

$54,092,000 (65.96%)

Accumulated Other Comprehensive Income

-$1,485,000 (-169.02%)

-$552,000 (88.85%)

-$4,949,000 (-649.85%)

-$660,000 (-415.63%)

Deferred Revenue

$13,576,000 (-75.16%)

$54,651,000 (-13.61%)

$63,260,000 (-37.39%)

$101,034,000 (-40.70%)

Total Investments

$730,647,000 (123.89%)

$326,349,000 (-33.55%)

$491,099,000 (-5.49%)

$519,629,000 (21.49%)

Investments Current

$368,488,000 (39.10%)

$264,915,000 (-21.80%)

$338,771,000 (-14.11%)

$394,442,000 (48.73%)

Investments Non-Current

$362,159,000 (489.51%)

$61,434,000 (-59.67%)

$152,328,000 (21.68%)

$125,187,000 (-22.98%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$15,000,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$5,989,000 (-15.35%)

$7,075,000 (63.21%)

$4,335,000 (8.24%)

$4,005,000 (-8.31%)

Accumulated Retained Earnings (Deficit)

-$754,610,000 (-42.18%)

-$530,752,000 (-38.29%)

-$383,790,000 (-67.61%)

-$228,982,000 (-77.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$87,761,000 (3.65%)

$84,674,000 (388.46%)

$17,335,000 (-3.50%)

$17,963,000 (-0.17%)

Debt Current

$13,112,000 (106.65%)

$6,345,000 (60.92%)

$3,943,000 (9.56%)

$3,599,000 (10.36%)

Debt Non-Current

$74,649,000 (-4.70%)

$78,329,000 (484.89%)

$13,392,000 (-6.77%)

$14,364,000 (-2.50%)

Total Liabilities

$142,416,000 (-21.22%)

$180,788,000 (60.01%)

$112,983,000 (-22.76%)

$146,267,000 (-28.05%)

Liabilities Current

$67,767,000 (-20.92%)

$85,691,000 (20.11%)

$71,343,000 (-22.91%)

$92,542,000 (-16.34%)

Liabilities Non-Current

$74,649,000 (-21.50%)

$95,097,000 (128.38%)

$41,640,000 (-22.49%)

$53,725,000 (-42.03%)

KYMR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$47,072,000 (-40.11%)

$78,592,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$63,534,000 (15.43%)

$55,041,000 (25.57%)

$43,834,000 (20.61%)

$36,345,000 (99.34%)

Research & Development Expense

$240,248,000 (27.06%)

$189,081,000 (15.12%)

$164,248,000 (19.87%)

$137,017,000 (120.62%)

Operating Expenses

$308,707,000 (26.46%)

$244,122,000 (17.32%)

$208,082,000 (20.03%)

$173,362,000 (115.79%)

Interest Expense

$249,000 (27.04%)

$196,000 (11.36%)

$176,000 (0.57%)

$175,000 (52.17%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$223,858,000 (-52.32%)

-$146,962,000 (5.07%)

-$154,808,000 (-54.47%)

-$100,217,000 (-119.81%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$223,858,000 (-52.32%)

-$146,962,000 (5.07%)

-$154,808,000 (-54.47%)

-$100,217,000 (-119.81%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$223,858,000 (-52.32%)

-$146,962,000 (5.07%)

-$154,808,000 (-54.47%)

-$100,217,000 (-83.40%)

Weighted Average Shares

$75,043,991 (28.58%)

$58,365,499 (8.22%)

$53,933,229 (12.39%)

$47,989,023 (176.60%)

Weighted Average Shares Diluted

$75,043,991 (28.58%)

$58,365,499 (8.22%)

$53,933,229 (12.39%)

$47,989,023 (176.60%)

Earning Before Interest & Taxes (EBIT)

-$223,609,000 (-52.36%)

-$146,766,000 (5.09%)

-$154,632,000 (-54.57%)

-$100,042,000 (-119.98%)

Gross Profit

$47,072,000 (-40.11%)

$78,592,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$261,635,000 (-58.06%)

-$165,530,000 (20.45%)

-$208,082,000 (-20.03%)

-$173,362,000 (-115.79%)

KYMR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$404,077,000 (-388.86%)

$139,886,000 (581.74%)

$20,519,000 (120.55%)

-$99,835,000 (76.38%)

Net Cash Flow from Financing

$608,851,000 (14424.12%)

$4,192,000 (-97.26%)

$152,999,000 (-38.87%)

$250,280,000 (-13.48%)

Net Cash Flow from Operations

-$194,501,000 (-89.16%)

-$102,826,000 (32.83%)

-$153,085,000 (-18.72%)

-$128,946,000 (-246.31%)

Net Cash Flow / Change in Cash & Cash Equivalents

$10,273,000 (-75.10%)

$41,252,000 (101.89%)

$20,433,000 (-4.96%)

$21,499,000 (147.57%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$391,239,000 (-324.38%)

$174,366,000 (646.59%)

$23,355,000 (123.77%)

-$98,238,000 (76.24%)

Capital Expenditure

-$12,838,000 (62.77%)

-$34,480,000 (-1115.80%)

-$2,836,000 (-77.58%)

-$1,597,000 (82.44%)

Issuance (Repayment) of Debt Securities

-$1,576,000 (-1973.68%)

-$76,000 (93.27%)

-$1,130,000 (-33.10%)

-$849,000 (-53.25%)

Issuance (Purchase) of Equity Shares

$610,427,000 (14202.41%)

$4,268,000 (-97.23%)

$154,129,000 (-38.63%)

$251,129,000 (27.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$55,012,000 (27.58%)

$43,118,000 (21.53%)

$35,480,000 (42.08%)

$24,972,000 (381.16%)

Depreciation Amortization & Accretion

$7,373,000 (106.82%)

$3,565,000 (19.75%)

$2,977,000 (24.20%)

$2,397,000 (35.96%)

KYMR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

-

Profit Margin

-475.60% (-154.33%)

-187.00%

-

-

EBITDA Margin

-459.40% (-152.14%)

-182.20%

-

-

Return on Average Equity (ROAE)

-28.70% (17.53%)

-34.80% (-2.96%)

-33.80% (-24.26%)

-27.20% (47.89%)

Return on Average Assets (ROAA)

-24.20% (4.35%)

-25.30% (4.89%)

-26.60% (-42.25%)

-18.70% (-3.31%)

Return on Sales (ROS)

-475.00% (-154.42%)

-186.70%

-

-

Return on Invested Capital (ROIC)

-26.40% (7.69%)

-28.60% (21.43%)

-36.40% (-32.85%)

-27.40% (-16.60%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-13.5 (-33.62%)

-10.1 (-16.17%)

-8.7 (71.37%)

-30.38 (-54.34%)

Price to Sales Ratio (P/S)

64.14 (239.20%)

18.91

-

-

Price to Book Ratio (P/B)

3.12 (-12.83%)

3.58 (28.02%)

2.79 (-60.64%)

7.1 (-26.90%)

Debt to Equity Ratio (D/E)

0.17 (-62.88%)

0.46 (98.27%)

0.23 (-27.36%)

0.32 (-55.59%)

Earnings Per Share (EPS)

-2.98 (-18.25%)

-2.52 (12.20%)

-2.87 (-37.32%)

-2.09 (33.65%)

Sales Per Share (SPS)

0.63 (-53.45%)

1.35 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.76 (-17.42%)

-2.35 (18.61%)

-2.89 (-6.29%)

-2.72 (-159.71%)

Book Value Per Share (BVPS)

11.13 (64.55%)

6.77 (-25.54%)

9.09 (-5.12%)

9.58 (-41.47%)

Tangible Assets Book Value Per Share (TABVPS)

13.03 (32.11%)

9.87 (-11.79%)

11.18 (-11.43%)

12.63 (-55.04%)

Enterprise Value Over EBIT (EV/EBIT)

-12 (-20.00%)

-10 (-25.00%)

-8 (74.19%)

-31 (48.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-11.92 (-21.34%)

-9.82 (-21.66%)

-8.07 (74.75%)

-31.98 (48.61%)

Asset Turnover

0.05 (-62.22%)

0.14 (0%)

0 (0%)

0 (0%)

Current Ratio

7.53 (59.20%)

4.73 (-19.54%)

5.88 (20.57%)

4.88 (78.41%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$207,339,000 (-51.01%)

-$137,306,000 (11.94%)

-$155,921,000 (-19.44%)

-$130,543,000 (-265.17%)

Enterprise Value (EV)

$2,577,236,973 (83.21%)

$1,406,706,517 (14.89%)

$1,224,389,586 (-60.79%)

$3,122,602,265 (14.79%)

Earnings Before Tax (EBT)

-$223,858,000 (-52.32%)

-$146,962,000 (5.07%)

-$154,808,000 (-54.47%)

-$100,217,000 (-119.81%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$216,236,000 (-51.00%)

-$143,201,000 (5.57%)

-$151,655,000 (-55.31%)

-$97,645,000 (-123.37%)

Invested Capital

$871,979,000 (89.99%)

$458,965,000 (-3.29%)

$474,601,000 (-0.55%)

$477,234,000 (31.85%)

Working Capital

$442,501,000 (38.44%)

$319,626,000 (-8.17%)

$348,073,000 (-2.97%)

$358,731,000 (87.11%)

Tangible Asset Value

$978,035,000 (69.87%)

$575,759,000 (-4.54%)

$603,134,000 (-0.46%)

$605,905,000 (24.37%)

Market Capitalization

$2,605,506,973 (84.43%)

$1,412,708,517 (3.16%)

$1,369,423,586 (-58.03%)

$3,262,569,265 (18.36%)

Average Equity

$781,169,000 (85.12%)

$421,984,750 (-7.75%)

$457,426,750 (23.95%)

$369,031,000 (252.33%)

Average Assets

$926,787,250 (59.52%)

$580,996,750 (-0.18%)

$582,021,750 (8.42%)

$536,824,000 (77.79%)

Invested Capital Average

$847,606,500 (65.32%)

$512,705,500 (20.68%)

$424,862,000 (16.41%)

$364,984,250 (88.38%)

Shares

64,765,274 (16.72%)

55,487,373 (1.13%)

54,864,727 (6.77%)

51,387,136 (15.58%)